These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development]. Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M Pol Arch Med Wewn; 2007; 117 Suppl():13-7. PubMed ID: 18778013 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to oxidised LDL. Vaarala O Lupus; 2000; 9(3):202-5. PubMed ID: 10805488 [TBL] [Abstract][Full Text] [Related]
9. Accelerated atheroma, antiphospholipid antibodies, and the antiphospholipid syndrome. George J; Haratz D; Shoenfeld Y Rheum Dis Clin North Am; 2001 Aug; 27(3):603-10, vii. PubMed ID: 11534263 [TBL] [Abstract][Full Text] [Related]
10. VWF, Platelets and the Antiphospholipid Syndrome. Huang S; Ninivaggi M; Chayoua W; de Laat B Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919627 [TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis? Sherer Y; Shoenfeld Y Immunobiology; 2003; 207(1):13-6. PubMed ID: 12638897 [TBL] [Abstract][Full Text] [Related]
12. Women's Issues in Antiphospholipid Syndrome. Papadakis E; Banti A; Kioumi A Isr Med Assoc J; 2016 Sep; 18(9):524-529. PubMed ID: 28471597 [TBL] [Abstract][Full Text] [Related]